Improved diabetes control in the elderly delays global cognitive decline

Journal of Nutrition, Health and Aging

Volumn 15, Issue 6, 2011, Pages 445-449

  Luchsinger, José A ^a,b   Palmas, Walter ^a   Teresi, J A ^a,c,d   Silver, S ^c   Kong, J ^c   Eimicke, J P ^c   Weinstock, R S ^e,f   Shea, S ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Hebrew Home at Riverdale ^*  (United States)

^c Hebrew Home in Riverdale   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

clinical trials; cognitive impairment; Diabetes treatment

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CASE MANAGEMENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES CONTROL; FEMALE; FOLLOW UP; GERIATRICS; GLOBAL COGNITION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TELEMEDICINE;

EID: 79960116360     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-011-0057-x     Document Type: Article

References (49)

1. J.A. Luchsinger C. Reitz B. Patel M.-X. Tang J.J. Manly R. Mayeux 2007 Relation of Diabetes to Mild Cognitive Impairment Arch Neurol 64 570 575 17420320 10.1001/archneur.64.4.570 (Pubitemid 46588347)
2. J.A. Luchsinger M.X. Tang Y. Stern S. Shea R. Mayeux 2001 Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort Am J Epidemiol 154 635 641 11581097 10.1093/aje/154.7.635 1:STN:280:DC%2BD3MrjvVKnsA%3D%3D (Pubitemid 32888781)
3. Prevention CfDCa. Fact Sheet Press Release: Number of People with Diabetes Increases to 24 million Volume 2008, 2008.
4. S. Shea R.S. Weinstock J.A. Teresi, et al. 2009 A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study J Am Med Inform Assoc 16 446 456 19390093 10.1197/jamia.M3157
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001;285: 2486-2497.
6. S.M. Grundy J.I. Cleeman C.N. Merz, et al. 2004 Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 227 239 15249516 10.1161/01.CIR.0000133317. 49796.0E (Pubitemid 38924592)
7. B. Gurland J. Kuriansky L. Sharpe R. Simon P. Stiller P. Birkett 1977 The Comprehensive assessment and Referral Evaluation (CARE)-rationale, development and reliability Int J Aging Hum Dev 8 9 42 873639 10.2190/CL3J-0E20-97XX-MV5L (Pubitemid 8156349)
8. B.J. Gurland D.E. Wilder P.E. Cross J.A. Teresi V.W. Barrett 1992 Screening scales for dementia: towards reconciliation of conflicting cross-cultural findings Int J Geriatr Psychiatry 7 105 113 10.1002/gps.930070207
9. E. Vittinghoff S. Sen C.E. McCulloch 2009 Sample size calculations for evaluating mediation Stat Med 28 541 557 19065627 10.1002/sim.3491 1:STN:280:DC%2BD1M%2FnvFSrsg%3D%3D
10. A. Sjolander 2009 Bounds on natural direct effects in the presence of confounded intermediate variables Stat Med 28 558 571 19035530 10.1002/sim.3493
11. D.P. MacKinnon C.M. Lockwood J.M. Hoffman S.G. West V. Sheets 2002 A comparison of methods to test mediation and other intervening variable effects Psychol Methods 7 83 104 11928892 10.1037/1082-989X.7.1.83
12. K.A. Pituch T.A. Whittaker L.M. Stapleton 2005 A comparison of methods to test for mediation in multisite experiments Multivariable Behavioral Research 40 1 23 10.1207/s15327906mbr4001-1 (Pubitemid 41365241)
13. Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. In: Leinhardt S, ed. Sociological methodology Washington, DC: American Sociological Association, 1982, pp. 290-312.
14. L.A. Aroian 1944 The probability function of the product of two normally distributed variables Ann Mathematical Statistics 18 265 271 10.1214/aoms/1177730442
15. J.L. Krull D.P. MacKinnon 1999 Multilevel mediation modeling in group-based intervention studies Eval Rev 23 418 444 10558394 10.1177/0193841X9902300404 1:STN:280:DyaK1MvktVeltw%3D%3D
16. D.P. MacKinnon C.M. Lockwood J. Williams 2008 Confidence limits for the indirect effect: Distribution of the product and resampling methods Multivariate Behavioral Research 39 99 128 10.1207/s15327906mbr3901-4 (Pubitemid 38882481)
17. K. Yaffe T. Blackwell A.M. Kanaya N. Davidowitz E. Barrett-Connor K. Krueger 2004 Diabetes, impaired fasting glucose, and development of cognitive impairment in older women Neurology 63 658 663 15326238 1:CAS:528: DC%2BD2cXmtlSjsLc%3D (Pubitemid 39100821)
18. Z. Arvanitakis R.S. Wilson J.L. Bienias D.A. Evans D.A. Bennett 2004 Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function Arch Neurol 61 661 666 15148141 10.1001/archneur.61.5.661 (Pubitemid 38637681)
19. C. MacKnight K. Rockwood E. Awalt I. McDowell 2002 Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging Dement Geriatr Cogn Disord 14 77 83 12145454 10.1159/000064928 (Pubitemid 36152948)
20. J.A. Luchsinger C. Reitz L.S. Honig M.X. Tang S. Shea R. Mayeux 2005 Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology 65 545 551 16116114 10.1212/01.wnl.0000172914.08967.dc 1:STN:280:DC%2BD2MvkvFChtQ%3D%3D (Pubitemid 41170713)
21. J.A. Luchsinger 2008 Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective Eur J Pharmacol 585 119 129 18384771 10.1016/j.ejphar.2008.02.048 1:CAS:528:DC%2BD1cXlsF2qu7Y%3D
22. T. Cukierman H.C. Gerstein J.D. Williamson 2005 Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies Diabetologia 48 2460 2469 16283246 10.1007/s00125-005-0023-4 1:STN:280:DC%2BD2Mnjsl2ruw%3D%3D (Pubitemid 41738208)
23. G.J. Biessels S. Staekenborg E. Brunner C. Brayne P. Scheltens 2006 Risk of dementia in diabetes mellitus: a systematic review Lancet Neurol 5 64 74 16361024 10.1016/S1474-4422(05)70284-2 (Pubitemid 41790697)
24. The Diabetes ControlComplications Trial/Epidemiology of Diabetes InterventionsComplications Study Research G. 2007 Long-Term Effect of Diabetes and Its Treatment on Cognitive Function N Engl J Med 356 1842 1852 10.1056/NEJMoa066397 (Pubitemid 46698465)
25. M. Negrean A. Stirban B. Stratmann, et al. 2007 Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus Am J Clin Nutr 85 1236 1243 17490958 1:CAS:528:DC%2BD2sXls1Kiur4%3D (Pubitemid 46740464)
26. H. Vlassara L.J. Striker S. Teichberg H. Fuh Y.M. Li M. Steffes 1994 Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats Proc Natl Acad Sci U S A 91 11704 11708 7972128 10.1073/pnas.91.24. 11704 1:CAS:528:DyaK2MXitlyrtbo%3D (Pubitemid 24356413)
27. M. Peppa H. Brem W. Cai, et al. 2006 Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711) Am J Nephrol 26 430 436 16974073 10.1159/000095786 1:CAS:528:DC%2BD28XhtlWnur%2FP (Pubitemid 44971733)
28. V. Thallas-Bonke C. Lindschau B. Rizkalla, et al. 2004 Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product crosslink breaker ALT-711 via a protein kinase C-alpha-dependent pathway Diabetes 53 2921 2930 15504973 10.2337/diabetes.53.11. 2921 1:CAS:528:DC%2BD2cXpvV2itLk%3D (Pubitemid 39425918)
29. A.W. Stitt 2001 Advanced glycation: an important pathological event in diabetic and age related ocular disease Br J Ophthalmol 85 746 753 11371498 10.1136/bjo.85.6.746 1:STN:280:DC%2BD3M3nslKrug%3D%3D (Pubitemid 32554256)
30. C.G. Schalkwijk M. Lieuw-a-Fa V.W. van Hinsbergh C.D. Stehouwer 2002 Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy Semin Vasc Med 2 191 197 16222610 10.1055/s-2002-32042
31. K.A. Sullivan E.L. Feldman 2005 New developments in diabetic neuropathy Curr Opin Neurol 18 586 590 16155445 10.1097/01.wco.0000178825.56414.52 1:CAS:528:DC%2BD2MXht1ans73E (Pubitemid 41476148)
32. S.D. Yan X. Chen J. Fu, et al. 1996 RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease Nature 382 685 691 8751438 10.1038/382685a0 1:CAS:528:DyaK28Xlt1yltr0%3D (Pubitemid 26282167)
33. A.M. Schmidt S.D. Yan S.F. Yan D.M. Stern 2000 The biology of the receptor for advanced glycation end products and its ligands Biochim Biophys Acta 1498 99 111 11108954 10.1016/S0167-4889(00)00087-2 1:CAS:528: DC%2BD3cXosFCjsrw%3D
34. L.F. Lue D.G. Walker L. Brachova, et al. 2001 Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism Exp Neurol 171 29 45 11520119 10.1006/exnr.2001.7732 1:CAS:528:DC%2BD3MXmtFyqtrc%3D (Pubitemid 32848443)
35. R. Deane S. Du Yan R.K. Submamaryan, et al. 2003 RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain Nat Med 9 907 913 12808450 10.1038/nm890 1:CAS:528:DC%2BD3sXkvFOjsL0%3D (Pubitemid 36889934)
36. J.E. Donahue S.L. Flaherty C.E. Johanson, et al. 2006 RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease Acta Neuropathol (Berl) 112 405 415 10.1007/s00401-006-0115-3 1:CAS:528:DC%2BD28XhtVagsrzN (Pubitemid 44469161)
37. H. Buschke P.A. Fuld 1974 Evaluating storage, retention, and retrieval in disordered memory and learning Neurology 24 1019 1025 4473151 1:STN:280:DyaE2M%2FjsVGkug%3D%3D
38. S.A. Small R. Mayeux 1999 A clinical approach to memory decline J Pract Psychiatry Behav Health 5 87 94
39. P.S. Sachdev H. Brodaty M.J. Valenzuela, et al. 2004 The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients Neurology 62 912 919 15037692 1:STN:280:DC%2BD2c7ksVeqtg%3D%3D (Pubitemid 38435778)
40. V. Hachinski C. Iadecola R.C. Petersen, et al. 2006 National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards Stroke 37 2220 2241 16917086 10.1161/01.STR.0000237236.88823.47 (Pubitemid 44337162)
41. D.J. Selkoe 2000 The origins of Alzheimer disease: a is for amyloid Jama 283 1615 1617 10735401 10.1001/jama.283.12.1615 1:STN:280:DC%2BD3c7pslCnug%3D%3D (Pubitemid 30161520)
42. S. Craft 2009 The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged Arch Neurol 66 300 305 19273747 10.1001/archneurol.2009.27
43. J.A. Luchsinger A.M. Brickman C. Reitz, et al. 2009 Subclinical cerebrovascular disease in mild cognitive impairment Neurology 73 450 456 19667320 10.1212/WNL.0b013e3181b1636a 1:STN:280:DC%2BD1MrksFOgug%3D%3D
44. Z. Arvanitakis J.A. Schneider R.S. Wilson, et al. 2006 Diabetes is related to cerebral infarction but not to AD pathology in older persons Neurology 67 1960 1965 17159101 10.1212/01.wnl.0000247053.45483.4e 1:STN:280:DC%2BD28jit1Kmuw%3D%3D (Pubitemid 44967371)
45. R.L. Sacco E.J. Benjamin J.P. Broderick, et al. 1997 American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors Stroke 28 1507 1517 9227708 1:STN:280:DyaK2szntFCrsQ%3D%3D
46. L.A. Moye 2000 Alpha calculus in clinical trials: considerations and commentary for the new millennium Stat Med 19 767 779 10734280 10.1002/(SICI)1097-0258(20000330)19:6<767::AID-SIM518>3.0.CO;2-U 1:STN:280:DC%2BD3c3gtVKgsQ%3D%3D (Pubitemid 30187375)
47. J.D. Williamson M.E. Miller R.N. Bryan, et al. 2007 The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods Am J Cardiol 99 112i 122i 17599421 10.1016/j.amjcard.2007.03.029 (Pubitemid 46961889)
48. R.A. Whitmer A.J. Karter K. Yaffe C.P. Quesenberry Jr. J.V. Selby 2009 Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus JAMA 301 1565 1572 19366776 10.1001/jama.2009.460 1:CAS:528:DC%2BD1MXksVyks7Y%3D
49. The Action to Control Cardiovascular Risk in Diabetes Study G. 2008 Effects of Intensive Glucose Lowering in Type 2 Diabetes N Engl J Med 358 2545 2559 10.1056/NEJMoa0802743 (Pubitemid 351831356)